A recent article in the Capital Business Journal, a Washington Post publication, about diversifying the local economy included information about how Children’s National is using data to help improve care for children with chronic conditions like sickle cell disease.
Read the article
Want the latest Children’s National news and stories as they happen? Sign up to get our News & Events releases by email.
Our blood and marrow transplant offers trials for cellular therapy to reduce infection and relapse in children with cancer
Children’s National provides a wide range of clinical services and specialties dedicated to improving children’s health.
Cellular therapy is a novel treatment for reducing infection and relapse in children with blood cancers.